Sierra Oncology, Inc. - Common Stock (NQ:SRRA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 30, 2022 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	54.96 (50)
Ask (Size)	55.00 (2)
Prev. Close	54.99
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	24,419,349
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease ↗

June 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration

June 17, 2022

From Sierra Oncology

Via Business Wire

Performance

More News

6 Biotech Stocks to Buy Now Ahead of These June Catalysts ↗

June 03, 2022

Via InvestorPlace

3 Biotech Stocks to Buy Before They Boom ↗

June 01, 2022

Via InvestorPlace

Recap: Sierra Oncology Q1 Earnings ↗

May 06, 2022

Via Benzinga

Analyst Ratings for Sierra Oncology ↗

April 14, 2022

Via Benzinga

Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting

May 26, 2022

From Sierra Oncology

Via Business Wire

Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meeting

May 12, 2022

From Sierra Oncology

Via Business Wire

Sierra Oncology Reports First Quarter 2022 Results

May 06, 2022

From Sierra Oncology

Via Business Wire

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 05, 2022

From Sierra Oncology

Via Business Wire

SIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRA

May 02, 2022

From Kuznicki Law PLLC

Via Business Wire

SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA

April 25, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More ↗

April 17, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022 ↗

April 14, 2022

Via Benzinga

Analyzing Sierra Oncology Inc's Short Interest ↗

April 14, 2022

Via Benzinga

Advancements of CAR-T Cell Therapies Importance Grows While Cancer Cases Increasing

April 14, 2022

Via FinancialNewsMedia

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 13, 2022

Via Benzinga

Why Is Creatd (CRTD) Stock Up Today? ↗

April 13, 2022

Via InvestorPlace

Dear KLDO Stock Fans, Mark Your Calendars for April 28 ↗

April 13, 2022

Via InvestorPlace

Why Is Sierra Oncology (SRRA) Stock Up Today? ↗

April 13, 2022

Via InvestorPlace

Sierra Oncology Stock Is Soaring: Here's Why ↗

April 13, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022 ↗

April 13, 2022

Via Benzinga

Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares ↗

April 13, 2022

Via Investor's Business Daily

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More ↗

April 13, 2022

Via Benzinga

SRRA Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Sierra Oncology, Inc. Is Fair to Shareholders

April 13, 2022

From Halper Sadeh LLP

Via Business Wire

Frequently Asked Questions

Is Sierra Oncology, Inc. - Common Stock publicly traded?

Yes, Sierra Oncology, Inc. - Common Stock is publicly traded.

What exchange does Sierra Oncology, Inc. - Common Stock trade on?

Sierra Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sierra Oncology, Inc. - Common Stock?

The ticker symbol for Sierra Oncology, Inc. - Common Stock is SRRA on the Nasdaq Stock Market